TCMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tactile Systems Technology Inc (TCMD) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance and positive analyst ratings, the lack of significant trading signals, insider selling, and limited short-term upside potential suggest holding off on immediate investment.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram (0.127), indicating a potential upward trend. However, RSI is neutral at 38.11, and the stock is trading near its pivot level (24.762), suggesting limited momentum in either direction.
Strong Q4 financial performance with revenue up 21.04% YoY and EPS up 15.00% YoY.
Positive analyst ratings with raised price targets (e.g., Piper Sandler raised to $42, Lake Street to $40).
Continued growth momentum in the lymphedema business, with FY2026 guidance above expectations.
Insider selling has increased significantly by 867.75% in the last month.
Hedge funds remain neutral, and there are no significant trading trends.
Stock trend analysis predicts a potential decline of -0.98% in the next week and -5.49% in the next month.
In Q4 2025, the company delivered strong financial results: Revenue increased to $103.59M (up 21.04% YoY), Net Income rose to $10.63M (up 9.45% YoY), EPS grew to $0.46 (up 15.00% YoY), and Gross Margin improved to 77.62% (up 4.23% YoY).
Analysts are generally positive on TCMD. BTIG, Lake Street, and Piper Sandler have Buy or Overweight ratings with price targets ranging from $38 to $42, citing strong Q4 results and growth in the lymphedema business. However, B. Riley remains Neutral, noting limited upside from current levels.
